Media Welcome to Guerbet Media section for journalists. The press releases are intended for their professional use. Find our latest press releases and our media resources. Media… Homepage Media Our Latest Press Releases Intrasense and Guerbet announce PMDA certification in Japan for DUOnco™ Pancreas, an AI software designed to support the reading of pancreatic areas on contrast-enhanced CT Read the article Changes to the Composition of Guerbet’s Board of Directors Read the article Guerbet announces an important milestone achievement in the “Vascular Embolization” indication for Lipiodol® Ultra Fluid (Iodinated ethyl esters of fatty acids of poppy seed oil) Read the article - Any - 2026 2025 2024 2023 2022 2021 2020 2019 2018 ApplyClear Filters Q1 2025 revenue Read the article H1 2025 revenue Read the article 2024 full-year results Read the article US Food and Drug Administration (FDA) grants Breakthrough Device status to Guerbet innovation: DUOnco™ Pancreas for early detection of pancreatic lesions Read the article DUOnco™ Bone : First CE marked AI algorithm for automatic detection of bone lesions on CT scan Read the article U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT Read the article 2024 revenue Read the article Revenue at September 30, 2024 Read the article Gadopiclenol (marketed under the name Elucirem® by Guerbet) receives the JFR* 2024 Innovation Award - Jury's Favorite category Read the article ‹ 1 2 Current page3 4 5 6 7 8 9 ›
Intrasense and Guerbet announce PMDA certification in Japan for DUOnco™ Pancreas, an AI software designed to support the reading of pancreatic areas on contrast-enhanced CT Read the article
Guerbet announces an important milestone achievement in the “Vascular Embolization” indication for Lipiodol® Ultra Fluid (Iodinated ethyl esters of fatty acids of poppy seed oil) Read the article
US Food and Drug Administration (FDA) grants Breakthrough Device status to Guerbet innovation: DUOnco™ Pancreas for early detection of pancreatic lesions Read the article
DUOnco™ Bone : First CE marked AI algorithm for automatic detection of bone lesions on CT scan Read the article
U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT Read the article
Gadopiclenol (marketed under the name Elucirem® by Guerbet) receives the JFR* 2024 Innovation Award - Jury's Favorite category Read the article
